To determine the effect of exogenous 1,25-dihydroxyvitamin D
], a physiologically active form of vitamin D 3 metabolites, has been used to elevate plasma calcium (Ca) concentration during 1 to 4 days post-injection and thereby prevent parturient paresis (parturient hypocalcemia) in dairy cows [2, 4, 5] . This metabolite has the advantage of a shorter biological life than vitamin D 3 ; therefore, toxicity problems are reduced [9] . The shorter biological life also requires a more accurate prediction of the time of parturition for full effectiveness [4] . Because a decrease in the plasma Ca level is most likely to occur within 1 or 2 days postpartum [11] , we suggest that exogenous 1,25(OH) 2 D 3 should be administered to cows during 1 to 3 days prepartum. Parturition can be induced to dairy cows using prostaglandin F 2 α (PGF 2 α ) within 2 or 3 days after injection [6] . In this short communication, cows received a single intramuscular injection of 1,25(OH) on Ca metabolism around parturition and to discuss the ability of this prophylactic regimen to prevent parturient paresis in cows.
The protocol and experimental design were approved by the Obihiro University of Agriculture and Veterinary Medicine, Laboratory Animal Care and Use Committee. Ten late-pregnant, multiparous Holstein cows (aged 3 to 4 years) were assigned to 1,25(OH) ). The cows stayed in an outside paddock during dry period until 275 days gestation, and were housed in an individual pen until 5 days postpartum. The cows were fed a ration of good quality hay, grass and corn silages, and commercial concentrate; providing daily 0.3% Ca and 0.2% phosphorus (P) of dry matter (DM) prepartum and 0.8% Ca and 0.4% P of DM postpartum.
Intramuscular injection of 1,25(OH)
and/or PGF 2 α was performed as close to 1 or 2 days before the predicted date of parturition. Date of parturition was predicted twice a day by rectal temperature, by observation of udder filling and oedema, and by swelling and relaxation of the vulva and pelvic ligaments [1] . The cows of 1,25(OH) group at 4 days postpartum. These two cows received Ca treatment (an intravenous infusion of 500 ml of 25% Ca borogluconate solution) [10, 12] by the referring veterinarian, and recovered immediately. The criteria to start this treatment were that the cow was in recumbency and was unable to stand up itself.
Wilcoxon rank-sum test was used to observe the difference of the values between two groups on the each day after parturition. The data after Ca treatment were excluded in two cows with parturient paresis. The procedures for statistical analyses were done using JMP 5.0.1J software (SAS, USA). The significance was set at p < 0.05. Table 1 shows plasma 1,25(OH) group showed a marked increase in plasma Ca and iP concentrations around parturition, whereas control group seemed to reveal a mild decrease in plasma Ca and iP and a small rise in Mg level around calving. Plasma concentrations of Ca (10.3 ± 0.7 to 11.5 ± 1.0 mg/dl) and iP (6.0 ± 1.9 to 7.9 ± 2.1 mg/dl) in 1,25(OH) 2 D 3 group were significantly higher than those in control during -0.5 to 3 days (8.3 ± 1.0 to 9.4 to 0.6 mg/dl; p < 0.05 or p < 0.01) and during -0.5 to 0.5 days (2.5 ± 1.5 to 4.1 ± 0.8 mg/dl; p < 0.05) after parturition, respectively. There was no significant difference in plasma Mg concentration between two groups.
The increase in plasma Ca and iP concentrations following the 1,25(OH) D 3 . This study was supported in part by a Grant-in-Aid for Scientific Research (Shourei-A No. 13760218) from Japan Society for the Promotion of Science and a grant from The 21st Century COE Program (A-1), Ministry of Education, Culture, Sports, Science, and Technology of Japan.
